Priority Research Centre for Asthma and Respiratory Diseases and Hunter Medical Research Institute, Faculty of Health and Medicine, The University of Newcastle, Callaghan, New South Wales, Australia.
Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia.
Respirology. 2015 Nov;20(8):1160-71. doi: 10.1111/resp.12642. Epub 2015 Sep 16.
Chronic obstructive pulmonary disease (COPD) frequently coexists with other conditions often known as comorbidities. The prevalence of most of the common comorbid conditions that accompany COPD has been widely reported. It is also recognized that comorbidities have significant health and economic consequences. Nevertheless, there is scant research examining how comorbidities should be assessed and managed in the context of COPD. Also, the underlying mechanisms linking COPD with its comorbidities are still not fully understood. Owing to these knowledge gaps, current disease-specific approaches provide clinicians with little guidance in terms of managing comorbid conditions in the clinical care of multi-diseased COPD patients. This review discusses the concepts of comorbidity and multi-morbidity in COPD in relation to the overall clinical outcome of COPD management. It also summarizes some of the currently available clinical scores used to measure comorbid conditions and their prognostic abilities. Furthermore, recent developments in the proposed mechanisms linking COPD with its comorbidities are discussed.
慢性阻塞性肺疾病(COPD)常与其他疾病同时存在,通常被称为合并症。伴随 COPD 的大多数常见合并症的患病率已被广泛报道。人们还认识到,合并症对健康和经济都有重大影响。然而,几乎没有研究探讨在 COPD 的背景下应如何评估和管理合并症。此外,将 COPD 与其合并症联系起来的潜在机制仍不完全清楚。由于这些知识空白,目前针对特定疾病的方法在 COPD 多病症患者的临床护理中,为临床医生管理合并症提供的指导甚少。这篇综述讨论了 COPD 中合并症和多种合并症的概念,以及 COPD 管理的整体临床结果。它还总结了一些目前用于测量合并症及其预后能力的临床评分。此外,还讨论了将 COPD 与其合并症联系起来的机制的最新进展。